Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label Phase 1 pharmacokinetic, tolerability, and safety study of
ondansetron and Hylenex given subcutaneously compared to ondansetron given intravenously,
intramuscularly, and orally in normal healthy volunteers.